Recurrent coagulopathy after antivenom treatment of crotalid snakebite

Gregory M. Bogdan, Richard C. Dart, Steve C. Falbo, Jude McNally, Daniel Spaite

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

Background. We studied whether recurrence of coagulopathy, defined as the return of a coagulation abnormality after initial normalization, occurred after the use of antivenin (Crotalidae) polyvalent. Methods. A retrospective, blinded, descriptive analysis of 354 consecutive cases of North American crotalid snake envenomation was done. Inclusion criteria were documented clinical evidence of crotalid snakebite, presence of a coagulopathy (platelet count < 150,000/mm3, prothrombin time above normal, or fibrinogen level <150 mg/dL), and treatment with antivenin (Crotalidae) polyvalent. Results. Of 112 cases with a coagulopathy extending beyond 6 hours after envenomation, 31 had sufficient coagulopathy testing to detect recurrence. Fourteen of these patients (45%) had recurrence of coagulopathy, and two cases were severe (fibrinogen level 29 mg/dL; platelet count 36,000/mm3). Conclusion. Recurrence of coagulopathy after envenomation by North American crotalid snakes may occur after use of antivenin (Crotalidae) polyvalent and can result in severe coagulation abnormalities.

Original languageEnglish (US)
Pages (from-to)562-566
Number of pages5
JournalSouthern Medical Journal
Volume93
Issue number6
DOIs
StatePublished - 2000

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Recurrent coagulopathy after antivenom treatment of crotalid snakebite'. Together they form a unique fingerprint.

  • Cite this